Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonists
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 16 (3) , 331-339
- https://doi.org/10.1016/0361-9230(86)90054-7
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Tumors producing chronic hyperprolactinemia do not alter [3H]spirerone binding and dopamine turnover in the corpus striatum of the female ratEuropean Journal of Pharmacology, 1983
- Effect of prolactin and estradiol on rat striatal dopamine receptorsLife Sciences, 1982
- Estrogen and haloperidol-induced versus handling-related catalepsy in male ratsPharmacology Biochemistry and Behavior, 1982
- Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbitsBrain Research, 1982
- Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Cysteamine reduces serum gonadotropin concentrations in adult male ratsLife Sciences, 1982
- The effect of haloperidol feeding on dopamine receptor number in ten mouse strainsClinical Genetics, 1981
- Neuropharmacological studies on the neuroleptic potential of domperidone (R33812)Journal of Pharmacy and Pharmacology, 1979
- Tolerance to haloperidol catalepsyEuropean Journal of Pharmacology, 1977
- Antipsychotic drugs stimulate prolactin releasePsychopharmacology, 1974